Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Yoshimura

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Research and Reports in Urology|September 2, 2017
Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case seriesKoichi Sugimoto, Takahiro Akiyama, Nobutaka Shimizu, et al.
IJU Case Reports|March 5, 2024
Inflammatory myofibroblastic tumor of the prostateKen Fukiage, Kazutoshi Fujita, Shingo Toyoda, et al.
International Journal of Clinical Oncology|December 24, 2015
Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinomaMasahiro Nozawa, Koichi Sugimoto, Takayuki Ohzeki, et al.
Lower Urinary Tract Symptoms|March 19, 2016
Efficacy of Adding Dutasteride to α-Blocker Therapy Treated Benign Prostatic Hyperplasia Patients with Small Volume Prostate (<30 mL)Mamoru Hashimoto, Nobutaka Shimizu, Koichi Sugimoto, et al.
IJU Case Reports|November 6, 2023
A case of neuroendocrine tumor at the external urethral meatus after total cystectomyKoji Miki, Kazutoshi Fujita, Ken Kuwahara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 17, 2006
[Paraganglioma of the urinary bladder: a case report]Koji Hatano, Naotsugu Ichimaru, Tetsuya Takao, et al.
Anticancer Research|June 26, 2024
Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate CancerYutaka Yamamoto, Mituhisa Nishimoto, Yasunori Akashi, et al.
Cancers|December 23, 2023
Prognostic Factors of Platinum-Refractory Advanced Urothelial Carcinoma Treated with PembrolizumabYasunori Akashi, Yutaka Yamamoto, Mamoru Hashimoto, et al.
International Immunopharmacology|March 4, 2014
Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinomaTakafumi Minami, Tomoko Minami, Nobutaka Shimizu, et al.
International Immunopharmacology|January 23, 2017
Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24<sup>+</sup> patients with renal cell carcinomaTakafumi Minami, Naoki Matsumura, Koichi Sugimoto, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Research and Reports in Urology|September 2, 2017
Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case seriesKoichi Sugimoto, Takahiro Akiyama, Nobutaka Shimizu, et al.
IJU Case Reports|March 5, 2024
Inflammatory myofibroblastic tumor of the prostateKen Fukiage, Kazutoshi Fujita, Shingo Toyoda, et al.
International Journal of Clinical Oncology|December 24, 2015
Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinomaMasahiro Nozawa, Koichi Sugimoto, Takayuki Ohzeki, et al.
Lower Urinary Tract Symptoms|March 19, 2016
Efficacy of Adding Dutasteride to α-Blocker Therapy Treated Benign Prostatic Hyperplasia Patients with Small Volume Prostate (<30 mL)Mamoru Hashimoto, Nobutaka Shimizu, Koichi Sugimoto, et al.
IJU Case Reports|November 6, 2023
A case of neuroendocrine tumor at the external urethral meatus after total cystectomyKoji Miki, Kazutoshi Fujita, Ken Kuwahara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|February 17, 2006
[Paraganglioma of the urinary bladder: a case report]Koji Hatano, Naotsugu Ichimaru, Tetsuya Takao, et al.
Anticancer Research|June 26, 2024
Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate CancerYutaka Yamamoto, Mituhisa Nishimoto, Yasunori Akashi, et al.
Cancers|December 23, 2023
Prognostic Factors of Platinum-Refractory Advanced Urothelial Carcinoma Treated with PembrolizumabYasunori Akashi, Yutaka Yamamoto, Mamoru Hashimoto, et al.
International Immunopharmacology|March 4, 2014
Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinomaTakafumi Minami, Tomoko Minami, Nobutaka Shimizu, et al.
International Immunopharmacology|January 23, 2017
Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24<sup>+</sup> patients with renal cell carcinomaTakafumi Minami, Naoki Matsumura, Koichi Sugimoto, et al.
Pageof 11